
Über diesen Podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
396 Folgen · Levenswetenschappen
BioCentury This Week
Neueste FolgeEp. 392 - Biotech markets: Pause before the storm?
Über diesen Podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Neue Folgen
- Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners6. Okt. · 30 Min.
- Ep. 390 - Live from Amsterdam: Grand Rounds Europe takeaways30. Sept. · 34 Min.
- Ep. 389 - IgA nephropathy, Overton hearing, reverse mergers' new look29. Sept. · 37 Min.
- Ep. 388 - Biotech IPOs, CAR T safety & pharma tariffs22. Sept. · 32 Min.
- Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs15. Sept. · 31 Min.
- Ep. 386 - Novartis misses, pharma deals analysis, MFN carve-outs9. Sept. · 35 Min.
- Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton1. Sept. · 36 Min.
- Ep. 384 - Back to School Special: The global FIH trials race28. Aug. · 43 Min.
- Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick25. Aug. · 19 Min.
- Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA18. Aug. · 25 Min.